Björn Redfors

ORCID: 0000-0002-4155-4451
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Imaging and Diagnostics
  • Coronary Interventions and Diagnostics
  • Acute Myocardial Infarction Research
  • Cardiac Valve Diseases and Treatments
  • Takotsubo Cardiomyopathy and Associated Phenomena
  • Cardiovascular Function and Risk Factors
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Cardiac, Anesthesia and Surgical Outcomes
  • Cardiac Structural Anomalies and Repair
  • Atrial Fibrillation Management and Outcomes
  • Cardiac pacing and defibrillation studies
  • Infective Endocarditis Diagnosis and Management
  • Health Systems, Economic Evaluations, Quality of Life
  • Cardiac electrophysiology and arrhythmias
  • Heart Failure Treatment and Management
  • Cardiac Health and Mental Health
  • Venous Thromboembolism Diagnosis and Management
  • Cardiac and Coronary Surgery Techniques
  • Mechanical Circulatory Support Devices
  • Cardiac Arrest and Resuscitation
  • Cardiovascular Issues in Pregnancy
  • Aortic Disease and Treatment Approaches
  • COVID-19 Clinical Research Studies
  • Cardiac Ischemia and Reperfusion
  • Statistical Methods in Clinical Trials

Sahlgrenska University Hospital
2016-2025

University of Gothenburg
2016-2025

Cardiovascular Research Foundation
2016-2025

Region Västra Götaland
2023-2025

Cornell University
2022-2025

Weill Cornell Medicine
2022-2025

National Academy of Medicine
2024-2025

New York Hospital Queens
2018-2024

Columbia University Irving Medical Center
2016-2024

NewYork–Presbyterian Hospital
2017-2024

In patients with aortic stenosis (AS), risk stratification for valve replacement (AVR) relies mainly on valve-related factors, symptoms and co-morbidities. We sought to evaluate the prognostic impact of a newly-defined staging classification characterizing extent extravalvular (extra-aortic valve) cardiac damage among severe AS undergoing AVR.Patients from PARTNER 2 trials were pooled classified according presence or absence as detected by echocardiography prior AVR: no (Stage 0), left...

10.1093/eurheartj/ehx381 article EN cc-by-nc European Heart Journal 2017-06-18

Abstract The coronavirus disease 2019 (COVID-19) can result in a hyperinflammatory state, leading to acute respiratory distress syndrome (ARDS), myocardial injury, and thrombotic complications, among other sequelae. Statins, which are known have anti-inflammatory antithrombotic properties, been studied the setting of viral infections, but their benefit has not assessed COVID-19. This is retrospective analysis patients admitted with COVID-19 from February 1 st through May 12 th , 2020 study...

10.1038/s41467-021-21553-1 article EN cc-by Nature Communications 2021-02-26
Michel Azizi Manish Saxena Yale Wang J. Stephen Jenkins Chandan Devireddy and 95 more Florian Rader Naomi D.L. Fisher Roland E. Schmieder Felix Mahfoud Jason B. Lindsey Kintur Sanghvi Thomas M. Todoran John Pacella John M. Flack Joost Daemen Andrew Sharp Philipp Lurz Michael J. Bloch Michael A. Weber Melvin D. Lobo Jan Basile Lisa Claude Helen Reeve-Stoffer Candace K. McClure Ajay J. Kirtane Christopher M. Mullin Candace K. McClure Lisa Thackeray Yongshi Wang Glenn M. Chertow Venita Chandra Harold Dauerman Thomas Kahan Steven Ullery Nirat Beohar Ozgen Dogan M Mokrzycki Scott Mullaney Björn Redfors Huseng Vefali Andreas Loening Ron Zagoria Nedaa Skeik Richard Bae Amy McMeans JoAnne Goldman Rose Peterson Isabelle Tutor Michael R. Harrison Angel Penning Janice P. Lea Amanda Fiebach Claudia Merlin Suhail Dohad Anne H. Tran Kirin Bhatia Piotr Sobieszczyk Ian Halliday Tay Munson Steven B. Laster Mathew Bunte Anthony R Hart Dana E. King Jamie Hall Courtney Krathen Luot Lewis Ashley Willitts Anthony Awkar Casey Palmer Anna Tecklenburg John Schindler Matthew F. Muldoon MaryJo Albright Tracy L. Nicholson Youseff Chami Abdul Moiz Hafiz Emily Starkey Kristal Adams Nelson L. Bernardo Judith H. Veis Hayder Hashim Suman Singh Donna Whitman Rick Stouffer Alan L. Hinderliter Meghan Allen Tatum Scholl Pete Fong James S. Gainer Sherron Crook Ellen Hatchcock Debbie L. Cohen Jay Giri Taisei Kobayashi Robin Neubauer Suveeksha Naidu Jai Radhakrishnan Candido Batres Suzanne Edwards Matheen Khuddus

Importance Two initial sham-controlled trials demonstrated that ultrasound renal denervation decreases blood pressure (BP) in patients with mild to moderate hypertension and is resistant treatment. Objective To study the efficacy safety of without confounding influence antihypertensive medications hypertension. Design, Setting, Participants Sham-controlled, randomized clinical trial outcome assessors blinded treatment assignment was conducted between January 14, 2019, March 25, 2022, at 37...

10.1001/jama.2023.0713 article EN JAMA 2023-02-28

Ultrasound renal denervation (uRDN) was shown to lower blood pressure (BP) in patients with uncontrolled hypertension (HTN). Establishing the magnitude and consistency of uRDN effect across HTN spectrum is clinically important.

10.1001/jamacardio.2023.0338 article EN cc-by-nc-nd JAMA Cardiology 2023-02-28

BackgroundFor patients with asymptomatic severe aortic stenosis and preserved left ventricular ejection fraction, current guidelines recommend routine clinical surveillance every 6 to 12 months. Data from randomized trials examining whether early intervention transcatheter aortic-valve replacement (TAVR) will improve outcomes in these are lacking.MethodsAt 75 centers the United States Canada, we randomly assigned, a 1:1 ratio, undergo TAVR transfemoral placement of balloon-expandable valve...

10.1056/nejmoa2405880 article EN New England Journal of Medicine 2024-10-28
Pamela S. Douglas Michael G. Nanna Michelle D. Kelsey Eric Yow Daniel B. Mark and 95 more Manesh R. Patel Campbell Rogers James E. Udelson Christopher B. Fordyce Nick Curzen Gianluca Pontone Pál Maurovich‐Horvat Bernard De Bruyne John P. Greenwood V. Marinescu Jonathon Leipsic Gregg W. Stone Ori Ben‐Yehuda Colin Berry Shea E. Hogan Björn Redfors Ziad A. Ali Robert A. Byrne Christopher M. Kramer Robert W. Yeh Beth Martinez Sarah Mullen Whitney Huey Kevin J. Anstrom Hussein R. Al‐Khalidi Sreekanth Vemulapalli Anthony N. DeMaria Andrew M. Kahn Robert Pelberg Stuart J. Pocock Binita Shah Ozgu M. Issever Marc P. Bonaca David Engel W. Schuyler Jones Derek Chow Patricia A. Cowper Melanie R. Daniels Yanhong Li Weibing Xing Michael Barry Stephen R. Bloom David Buck Jane Cao Jeffrey D. Carstens Justin Carter Benjamin J.W. Chow George S. Chrysant Jason Cole Derek Connolly Ryan Daly Sorin Danciu Melissa A. Daubert Roderick C. Deaño Peter Fail Timothy Fairbairn Maros Ferencik Thomas H. Hauser Peter Haworth Mohammad Reza Hojjati Angela Hoye Mark Ibrahim Fuad Jan C. T. Kadalie Dinesh Kalra Ronald P. Karlsberg Steven Kindsvater John Kobayashi David Landers James A. Lee Diana Litmanovich Scott M. Matson David McAllister Gerry P McCann Mark A. Meier Nicolai Mejevoi Béla Merkely Jamaluddin Moloo Michael D. Morris Darra Murphy Nasar Nallamothu Anna Narezkina Katarina Nelson Tuan Nguyen Koen Nieman Prabhjot S. Nijjar Peter O’Kane Amit N. Patel Hena Patel Thomas Phiambolis Amit Pursnani Mark Rabbat Steven Raible Frederic S. Resnic Michael Salerno

Importance Trials showing equivalent or better outcomes with initial evaluation using coronary computed tomography angiography (cCTA) compared stress testing in patients stable chest pain have informed guidelines but raise questions about overtesting and excess catheterization. Objective To test a modified cCTA strategy designed to improve clinical efficiency vs usual (UT). Design, Setting, Participants This was pragmatic randomized trial enrolling participants from December 3, 2018, May 18,...

10.1001/jamacardio.2023.2595 article EN cc-by-nc-nd JAMA Cardiology 2023-08-23

Abstract The win ratio was introduced in 2012 as a new method for examining composite endpoints and has since been widely adopted cardiovascular (CV) trials. Improving upon conventional methods analysing endpoints, the accounts relative priorities of components allows to be different types outcomes. For example, can combine time death with number occurrences non-fatal outcome such CV-related hospitalizations (CVHs) single hierarchical endpoint. provide greater statistical power detect...

10.1093/eurheartj/ehaa665 article EN European Heart Journal 2020-08-04

Background Cardiovascular disease is the most common cause of death for both genders. Debates are ongoing as to whether gender‐specific differences in clinical course, diagnosis, and management acute myocardial infarction (MI) exist. Methods Results We compared all men women who were treated MI at cardiac care units Västra Götaland, Sweden, between January 1995 October 2014 by obtaining data from prospective SWEDEHEART (Swedish Web‐System Enhancement Evidence‐Based Care Heart Disease...

10.1161/jaha.115.001995 article EN cc-by-nc-nd Journal of the American Heart Association 2015-07-15
Coming Soon ...